NewsRx

Search our medical news database

Chagas Disease

AcroMetrix Announces Launch of PeliSpy Chagas Positive Control

Published in Blood Weekly, November 22nd, 2007

AcroMetrix announced the launch of the PeliSpy Chagas Positive Control. This external run control is intended to provide the laboratory a means of estimating precision and reproducibility of assays that detect antibodies to the Trypanosoma cruzi (T. cruzi) parasite, the cause of Chagas disease.

Chagas disease is a potentially deadly infection which often does not exhibit symptoms for up to 40 years. It is now endemic to most of Central and South America, with an increasing number of new cases reported in the US every year. Some experts estimate as many as 100,000 legal immigrants to the US and Canada are unknowingly infected with T. cruzi. The parasite may be spread...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook